As increased nuclear levels of NRF2 protein have been documented in gastric cancer cell lines and tissues [259], but the frequency of somatic mutations in NFE2L2, KEAP1 and CUL3 is low, it is likely that NRF2 can be upregulated by other mechanisms in GC. The gene discussed is NFE2L2; the disease is gastric cancer.